Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Douglas K. Bratton currently holds 9,984,836 shares of Denali Therapeutics Inc. (DNLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Douglas K. Bratton has been a net seller of DNLI stock. They have purchased $15.0M and sold $166.4M worth of shares.
Douglas K. Bratton's most recent insider trade was on Feb 12, 2021, when they sold 2,216,798 shares at $65.00 per share.
Douglas K. Bratton serves as Executive at Denali Therapeutics Inc. (DNLI). They have executed 14 insider transactions totaling $181.4M over their tenure at the company.
Douglas K. Bratton holds the position of Executive at Denali Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Douglas K. Bratton has shown a selling trading pattern, with $15.0M in total purchases and $166.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Douglas K. Bratton was on Feb 12, 2021, when they sold $144.1M worth of DNLI shares. This transaction involved 2,216,798 shares at $65.00 per share.
Douglas K. Bratton currently owns 9,984,836 shares of Denali Therapeutics Inc. (DNLI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Douglas K. Bratton's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Douglas K. Bratton has 14 Form 4 filings on record as an insider at Denali Therapeutics Inc..
Set alerts for Douglas K. Bratton and 40,000+ other insiders.